Mathew Blackman
Stock Analyst at Stifel
(4.50)
# 306
Out of 4,711 analysts
53
Total ratings
60.53%
Success rate
19.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $17.43 | +37.69% | 5 | Nov 8, 2024 | |
| GMED Globus Medical | Maintains: Buy | $80 → $92 | $82.63 | +11.34% | 4 | Nov 6, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.58 | +89.87% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $242.54 | -1.87% | 1 | Sep 17, 2024 | |
| NARI Inari Medical | Initiates: Hold | $50 | $55.45 | -9.83% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $80.04 | +24.94% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $9.35 | +71.12% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $35.91 | +67.08% | 5 | May 29, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $8.48 | -17.45% | 12 | May 8, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $15.55 | -42.10% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $163 → $208 | $266.57 | -21.97% | 2 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $10.28 | +7.00% | 4 | May 10, 2023 |
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $17.43
Upside: +37.69%
Globus Medical
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $92
Current: $82.63
Upside: +11.34%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.58
Upside: +89.87%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $242.54
Upside: -1.87%
Inari Medical
Sep 17, 2024
Initiates: Hold
Price Target: $50
Current: $55.45
Upside: -9.83%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $80.04
Upside: +24.94%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $9.35
Upside: +71.12%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $35.91
Upside: +67.08%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $8.48
Upside: -17.45%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $15.55
Upside: -42.10%
Feb 5, 2024
Maintains: Hold
Price Target: $163 → $208
Current: $266.57
Upside: -21.97%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $10.28
Upside: +7.00%